Shenzhen Salubris Pharmaceuticals Co., Ltd.

¥31.21As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002294Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.13%
Div yield 1.76%
ROE 7.99%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.20)
PE TTM 48.83
TSR TTM (46.80%)
Mkt cap ¥34.53B
ROIC 9.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥32
2.45%
(46.67%)
Sell 4|9|1|1|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.37
0.38
0.39
0.40
30.15%
31.16%
25.59%
17.63%
Revenue¥B
1.662
1.692
1.659
1.726
7.78%
8.54%
3.31%
6.56%
Peers (US$5.177B)
Cap (US$)
PE
5.269B
40.09x
5.235B
16.68x
Capital
TTM
5Y
10Y
Leveragex
1.182
0.086
0.086
EBIT/Intx
1.331
0.110
0.143
Own earn%
(54.40)
100.01
56.81
Sh yield%
38.09
32.27
30.27
Owners
Insiders/Inst%
1.10
34.40
Short interest%
3.03
SBC / revenue%
4.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
20–31
$1 testx
—
Incr. ROIC%
−1